Michael Bonelli

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Lisa Schneider

Medical University of Vienna

AUSTRIA

View details

Gregor Bond

AUSTRIA

View details

Venugopal Gudipati

Medical University of Vienna

AUSTRIA

View details

Paul Studenic

Karolinska Institutet

SWEDEN

View details

Renate Kain

Medical University of Vienna

AUSTRIA

View details

Felix Bergmann

Medical University of Vienna

AUSTRIA

View details

Markus Hoffmann

Professor

University of Lübeck

GERMANY

View details

Thomas Perkmann

Medical University of Vienna

AUSTRIA

View details

Helmuth Haslacher

AUSTRIA

View details

Ursula Wiedermann

Medical University of Vienna

AUSTRIA

View details

Elisabeth Simader

Medical University of Vienna

AUSTRIA

View details

Daniel Mrak

Medical University of Vienna

AUSTRIA

View details

Andreas Kerschbaumer

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Bonelli

Research Interests

Explore related searches

Contact this professor

Articles (13)

HDAC1 fine-tunes Th17 polarization in vivo to restrain tissue damage in fungal infections

Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial

Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis

Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers.

TNFR2 is critical for TNF-induced rheumatoid arthritis fibroblast-like synoviocyte inflammation.

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs).

Collaborators (13)

Lisa Schneider

Gregor Bond

Venugopal Gudipati

Paul Studenic

Renate Kain

Felix Bergmann

Markus Hoffmann

Thomas Perkmann

Helmuth Haslacher

Ursula Wiedermann

Elisabeth Simader

Daniel Mrak

Andreas Kerschbaumer

Make your next move.